nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—type 1 diabetes mellitus	0.47	1	CbGaD
Tacrolimus—Psychomotor skills impaired—Ramipril—type 1 diabetes mellitus	0.0223	0.119	CcSEcCtD
Tacrolimus—ORM1—saliva—type 1 diabetes mellitus	0.00977	0.0944	CbGeAlD
Tacrolimus—ABCA5—islet of Langerhans—type 1 diabetes mellitus	0.00775	0.0749	CbGeAlD
Tacrolimus—Infarction—Ramipril—type 1 diabetes mellitus	0.0067	0.0357	CcSEcCtD
Tacrolimus—ABCA5—retina—type 1 diabetes mellitus	0.00663	0.064	CbGeAlD
Tacrolimus—ABCA5—nephron tubule—type 1 diabetes mellitus	0.00624	0.0603	CbGeAlD
Tacrolimus—ABCA5—pancreas—type 1 diabetes mellitus	0.00545	0.0526	CbGeAlD
Tacrolimus—PPP3CA—islet of Langerhans—type 1 diabetes mellitus	0.00524	0.0506	CbGeAlD
Tacrolimus—PPP3CA—retina—type 1 diabetes mellitus	0.00448	0.0433	CbGeAlD
Tacrolimus—PPP3CA—nephron tubule—type 1 diabetes mellitus	0.00422	0.0407	CbGeAlD
Tacrolimus—Depressed mood—Ramipril—type 1 diabetes mellitus	0.00416	0.0222	CcSEcCtD
Tacrolimus—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.00385	0.0205	CcSEcCtD
Tacrolimus—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.00385	0.0205	CcSEcCtD
Tacrolimus—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.00379	0.0202	CcSEcCtD
Tacrolimus—PPP3CA—cardiovascular system—type 1 diabetes mellitus	0.00379	0.0366	CbGeAlD
Tacrolimus—PPP3CA—kidney—type 1 diabetes mellitus	0.00371	0.0358	CbGeAlD
Tacrolimus—PPP3CA—pancreas—type 1 diabetes mellitus	0.00368	0.0356	CbGeAlD
Tacrolimus—MTOR—retina—type 1 diabetes mellitus	0.00331	0.0319	CbGeAlD
Tacrolimus—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.0032	0.0171	CcSEcCtD
Tacrolimus—PPP3CA—lymphoid tissue—type 1 diabetes mellitus	0.00318	0.0307	CbGeAlD
Tacrolimus—FKBP1A—retina—type 1 diabetes mellitus	0.00298	0.0287	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.00295	0.0285	CbGeAlD
Tacrolimus—MTOR—cardiovascular system—type 1 diabetes mellitus	0.0028	0.027	CbGeAlD
Tacrolimus—MTOR—kidney—type 1 diabetes mellitus	0.00274	0.0264	CbGeAlD
Tacrolimus—MTOR—pancreas—type 1 diabetes mellitus	0.00272	0.0263	CbGeAlD
Tacrolimus—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00268	0.0143	CcSEcCtD
Tacrolimus—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00268	0.0143	CcSEcCtD
Tacrolimus—FKBP1A—cardiovascular system—type 1 diabetes mellitus	0.00252	0.0243	CbGeAlD
Tacrolimus—FKBP1A—kidney—type 1 diabetes mellitus	0.00246	0.0238	CbGeAlD
Tacrolimus—FKBP1A—pancreas—type 1 diabetes mellitus	0.00245	0.0236	CbGeAlD
Tacrolimus—MTOR—lymphoid tissue—type 1 diabetes mellitus	0.00235	0.0227	CbGeAlD
Tacrolimus—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.00231	0.0123	CcSEcCtD
Tacrolimus—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00224	0.012	CcSEcCtD
Tacrolimus—Liver injury—Ramipril—type 1 diabetes mellitus	0.00221	0.0118	CcSEcCtD
Tacrolimus—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00212	0.0113	CcSEcCtD
Tacrolimus—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.00212	0.0113	CcSEcCtD
Tacrolimus—FKBP1A—lymphoid tissue—type 1 diabetes mellitus	0.00212	0.0204	CbGeAlD
Tacrolimus—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00209	0.0111	CcSEcCtD
Tacrolimus—Cough increased—Ramipril—type 1 diabetes mellitus	0.00203	0.0108	CcSEcCtD
Tacrolimus—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00198	0.0106	CcSEcCtD
Tacrolimus—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00195	0.0104	CcSEcCtD
Tacrolimus—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00195	0.0104	CcSEcCtD
Tacrolimus—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00186	0.00992	CcSEcCtD
Tacrolimus—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00176	0.00936	CcSEcCtD
Tacrolimus—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00175	0.00931	CcSEcCtD
Tacrolimus—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00169	0.00901	CcSEcCtD
Tacrolimus—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00154	0.0082	CcSEcCtD
Tacrolimus—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00152	0.00812	CcSEcCtD
Tacrolimus—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.00152	0.0146	CbGeAlD
Tacrolimus—Deafness—Ramipril—type 1 diabetes mellitus	0.00151	0.00805	CcSEcCtD
Tacrolimus—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.0015	0.00801	CcSEcCtD
Tacrolimus—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0015	0.00797	CcSEcCtD
Tacrolimus—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00148	0.0079	CcSEcCtD
Tacrolimus—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00146	0.0078	CcSEcCtD
Tacrolimus—Amnesia—Ramipril—type 1 diabetes mellitus	0.00144	0.00766	CcSEcCtD
Tacrolimus—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00143	0.00763	CcSEcCtD
Tacrolimus—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00143	0.0076	CcSEcCtD
Tacrolimus—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00142	0.00756	CcSEcCtD
Tacrolimus—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.0014	0.00744	CcSEcCtD
Tacrolimus—Arthritis—Ramipril—type 1 diabetes mellitus	0.00139	0.00741	CcSEcCtD
Tacrolimus—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00138	0.00738	CcSEcCtD
Tacrolimus—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00138	0.00738	CcSEcCtD
Tacrolimus—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00136	0.00723	CcSEcCtD
Tacrolimus—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00127	0.00674	CcSEcCtD
Tacrolimus—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00125	0.00665	CcSEcCtD
Tacrolimus—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00123	0.00657	CcSEcCtD
Tacrolimus—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00122	0.0065	CcSEcCtD
Tacrolimus—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.00122	0.0118	CbGeAlD
Tacrolimus—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00122	0.00648	CcSEcCtD
Tacrolimus—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00122	0.00648	CcSEcCtD
Tacrolimus—Gastritis—Ramipril—type 1 diabetes mellitus	0.0012	0.00637	CcSEcCtD
Tacrolimus—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00117	0.00622	CcSEcCtD
Tacrolimus—Influenza—Ramipril—type 1 diabetes mellitus	0.00117	0.00622	CcSEcCtD
Tacrolimus—Asthma—Ramipril—type 1 diabetes mellitus	0.00117	0.00622	CcSEcCtD
Tacrolimus—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00114	0.0061	CcSEcCtD
Tacrolimus—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00114	0.00606	CcSEcCtD
Tacrolimus—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00114	0.00606	CcSEcCtD
Tacrolimus—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00112	0.00598	CcSEcCtD
Tacrolimus—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00111	0.00591	CcSEcCtD
Tacrolimus—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00109	0.00582	CcSEcCtD
Tacrolimus—CYP3A5—kidney—type 1 diabetes mellitus	0.00107	0.0104	CbGeAlD
Tacrolimus—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00107	0.00568	CcSEcCtD
Tacrolimus—CYP3A5—pancreas—type 1 diabetes mellitus	0.00107	0.0103	CbGeAlD
Tacrolimus—Weight increased—Ramipril—type 1 diabetes mellitus	0.00106	0.00566	CcSEcCtD
Tacrolimus—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00103	0.0055	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00103	0.00547	CcSEcCtD
Tacrolimus—Renal failure—Ramipril—type 1 diabetes mellitus	0.00102	0.00545	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00102	0.00544	CcSEcCtD
Tacrolimus—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00102	0.00544	CcSEcCtD
Tacrolimus—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00101	0.00541	CcSEcCtD
Tacrolimus—Jaundice—Ramipril—type 1 diabetes mellitus	0.00101	0.00541	CcSEcCtD
Tacrolimus—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00101	0.00539	CcSEcCtD
Tacrolimus—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00101	0.00539	CcSEcCtD
Tacrolimus—Sweating—Ramipril—type 1 diabetes mellitus	0.000998	0.00532	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000984	0.00525	CcSEcCtD
Tacrolimus—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000982	0.00523	CcSEcCtD
Tacrolimus—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000977	0.0052	CcSEcCtD
Tacrolimus—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000971	0.00518	CcSEcCtD
Tacrolimus—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000934	0.00498	CcSEcCtD
Tacrolimus—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000921	0.00491	CcSEcCtD
Tacrolimus—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000918	0.00489	CcSEcCtD
Tacrolimus—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000901	0.0048	CcSEcCtD
Tacrolimus—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000884	0.00471	CcSEcCtD
Tacrolimus—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000871	0.00464	CcSEcCtD
Tacrolimus—Flushing—Ramipril—type 1 diabetes mellitus	0.000867	0.00462	CcSEcCtD
Tacrolimus—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000844	0.0045	CcSEcCtD
Tacrolimus—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000842	0.00449	CcSEcCtD
Tacrolimus—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000835	0.00445	CcSEcCtD
Tacrolimus—Alopecia—Ramipril—type 1 diabetes mellitus	0.000826	0.0044	CcSEcCtD
Tacrolimus—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000819	0.00436	CcSEcCtD
Tacrolimus—Erythema—Ramipril—type 1 diabetes mellitus	0.000813	0.00434	CcSEcCtD
Tacrolimus—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000813	0.00434	CcSEcCtD
Tacrolimus—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000805	0.00777	CbGeAlD
Tacrolimus—CYP3A4—kidney—type 1 diabetes mellitus	0.000805	0.00777	CbGeAlD
Tacrolimus—Tension—Ramipril—type 1 diabetes mellitus	0.000798	0.00425	CcSEcCtD
Tacrolimus—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000797	0.00425	CcSEcCtD
Tacrolimus—Nervousness—Ramipril—type 1 diabetes mellitus	0.00079	0.00421	CcSEcCtD
Tacrolimus—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000782	0.00417	CcSEcCtD
Tacrolimus—Tremor—Ramipril—type 1 diabetes mellitus	0.000762	0.00406	CcSEcCtD
Tacrolimus—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000755	0.00402	CcSEcCtD
Tacrolimus—Agitation—Ramipril—type 1 diabetes mellitus	0.000748	0.00398	CcSEcCtD
Tacrolimus—Malaise—Ramipril—type 1 diabetes mellitus	0.000734	0.00391	CcSEcCtD
Tacrolimus—Vertigo—Ramipril—type 1 diabetes mellitus	0.000731	0.00389	CcSEcCtD
Tacrolimus—Syncope—Ramipril—type 1 diabetes mellitus	0.000729	0.00389	CcSEcCtD
Tacrolimus—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000728	0.00388	CcSEcCtD
Tacrolimus—Palpitations—Ramipril—type 1 diabetes mellitus	0.000719	0.00383	CcSEcCtD
Tacrolimus—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000715	0.00381	CcSEcCtD
Tacrolimus—Cough—Ramipril—type 1 diabetes mellitus	0.00071	0.00378	CcSEcCtD
Tacrolimus—Convulsion—Ramipril—type 1 diabetes mellitus	0.000705	0.00376	CcSEcCtD
Tacrolimus—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000693	0.00369	CcSEcCtD
Tacrolimus—Myalgia—Ramipril—type 1 diabetes mellitus	0.000693	0.00369	CcSEcCtD
Tacrolimus—Chest pain—Ramipril—type 1 diabetes mellitus	0.000693	0.00369	CcSEcCtD
Tacrolimus—Anxiety—Ramipril—type 1 diabetes mellitus	0.00069	0.00368	CcSEcCtD
Tacrolimus—ABCB1—retina—type 1 diabetes mellitus	0.000688	0.00665	CbGeAlD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000688	0.00367	CcSEcCtD
Tacrolimus—Discomfort—Ramipril—type 1 diabetes mellitus	0.000684	0.00365	CcSEcCtD
Tacrolimus—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000677	0.00361	CcSEcCtD
Tacrolimus—Confusional state—Ramipril—type 1 diabetes mellitus	0.000669	0.00357	CcSEcCtD
Tacrolimus—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000664	0.00354	CcSEcCtD
Tacrolimus—Oedema—Ramipril—type 1 diabetes mellitus	0.000664	0.00354	CcSEcCtD
Tacrolimus—Shock—Ramipril—type 1 diabetes mellitus	0.000653	0.00348	CcSEcCtD
Tacrolimus—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000651	0.00347	CcSEcCtD
Tacrolimus—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00065	0.00346	CcSEcCtD
Tacrolimus—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000648	0.00626	CbGeAlD
Tacrolimus—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000648	0.00345	CcSEcCtD
Tacrolimus—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000645	0.00344	CcSEcCtD
Tacrolimus—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000642	0.00342	CcSEcCtD
Tacrolimus—Anorexia—Ramipril—type 1 diabetes mellitus	0.000633	0.00337	CcSEcCtD
Tacrolimus—Hypotension—Ramipril—type 1 diabetes mellitus	0.00062	0.00331	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000605	0.00322	CcSEcCtD
Tacrolimus—Insomnia—Ramipril—type 1 diabetes mellitus	0.0006	0.0032	CcSEcCtD
Tacrolimus—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000596	0.00318	CcSEcCtD
Tacrolimus—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000592	0.00315	CcSEcCtD
Tacrolimus—Somnolence—Ramipril—type 1 diabetes mellitus	0.00059	0.00315	CcSEcCtD
Tacrolimus—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000584	0.00311	CcSEcCtD
Tacrolimus—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000582	0.00562	CbGeAlD
Tacrolimus—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000577	0.00308	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000573	0.00305	CcSEcCtD
Tacrolimus—Fatigue—Ramipril—type 1 diabetes mellitus	0.000572	0.00305	CcSEcCtD
Tacrolimus—ABCB1—kidney—type 1 diabetes mellitus	0.00057	0.0055	CbGeAlD
Tacrolimus—Constipation—Ramipril—type 1 diabetes mellitus	0.000568	0.00303	CcSEcCtD
Tacrolimus—ABCB1—pancreas—type 1 diabetes mellitus	0.000566	0.00547	CbGeAlD
Tacrolimus—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000547	0.00292	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000543	0.00289	CcSEcCtD
Tacrolimus—Urticaria—Ramipril—type 1 diabetes mellitus	0.000527	0.00281	CcSEcCtD
Tacrolimus—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000525	0.0028	CcSEcCtD
Tacrolimus—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000525	0.0028	CcSEcCtD
Tacrolimus—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000489	0.00473	CbGeAlD
Tacrolimus—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000489	0.00261	CcSEcCtD
Tacrolimus—Asthenia—Ramipril—type 1 diabetes mellitus	0.000476	0.00254	CcSEcCtD
Tacrolimus—Pruritus—Ramipril—type 1 diabetes mellitus	0.00047	0.0025	CcSEcCtD
Tacrolimus—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000454	0.00242	CcSEcCtD
Tacrolimus—Dizziness—Ramipril—type 1 diabetes mellitus	0.000439	0.00234	CcSEcCtD
Tacrolimus—Vomiting—Ramipril—type 1 diabetes mellitus	0.000422	0.00225	CcSEcCtD
Tacrolimus—Rash—Ramipril—type 1 diabetes mellitus	0.000419	0.00223	CcSEcCtD
Tacrolimus—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000418	0.00223	CcSEcCtD
Tacrolimus—Headache—Ramipril—type 1 diabetes mellitus	0.000416	0.00222	CcSEcCtD
Tacrolimus—Nausea—Ramipril—type 1 diabetes mellitus	0.000394	0.0021	CcSEcCtD
Tacrolimus—ALB—Folate Metabolism—IL6—type 1 diabetes mellitus	6.21e-05	0.000261	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—type 1 diabetes mellitus	6.19e-05	0.00026	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	6.19e-05	0.00026	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—type 1 diabetes mellitus	6.16e-05	0.000259	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	6.15e-05	0.000258	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	6.14e-05	0.000258	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—type 1 diabetes mellitus	6.13e-05	0.000257	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HLA-A—type 1 diabetes mellitus	6.12e-05	0.000257	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	6.11e-05	0.000256	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CRP—type 1 diabetes mellitus	6.1e-05	0.000256	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—type 1 diabetes mellitus	6.1e-05	0.000256	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TYK2—type 1 diabetes mellitus	6.09e-05	0.000256	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—GCG—type 1 diabetes mellitus	6.08e-05	0.000255	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.07e-05	0.000255	CbGpPWpGaD
Tacrolimus—MTOR—Disease—B2M—type 1 diabetes mellitus	5.99e-05	0.000251	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	5.97e-05	0.000251	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—STAT3—type 1 diabetes mellitus	5.97e-05	0.00025	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	5.89e-05	0.000247	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HBA2—type 1 diabetes mellitus	5.86e-05	0.000246	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	5.85e-05	0.000246	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	5.84e-05	0.000245	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	5.77e-05	0.000242	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	5.77e-05	0.000242	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	5.74e-05	0.000241	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	5.74e-05	0.000241	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—type 1 diabetes mellitus	5.74e-05	0.000241	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DPB1—type 1 diabetes mellitus	5.74e-05	0.000241	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IFNG—type 1 diabetes mellitus	5.7e-05	0.000239	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—type 1 diabetes mellitus	5.69e-05	0.000239	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	5.69e-05	0.000239	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCR5—type 1 diabetes mellitus	5.67e-05	0.000238	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	5.67e-05	0.000238	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-E—type 1 diabetes mellitus	5.65e-05	0.000237	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	5.64e-05	0.000237	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TYK2—type 1 diabetes mellitus	5.62e-05	0.000236	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	5.61e-05	0.000236	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—type 1 diabetes mellitus	5.61e-05	0.000236	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GAL—type 1 diabetes mellitus	5.6e-05	0.000235	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—STAT3—type 1 diabetes mellitus	5.6e-05	0.000235	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.59e-05	0.000235	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.55e-05	0.000233	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL11—type 1 diabetes mellitus	5.54e-05	0.000232	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL20—type 1 diabetes mellitus	5.54e-05	0.000232	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS3—type 1 diabetes mellitus	5.52e-05	0.000232	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	5.51e-05	0.000231	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD4—type 1 diabetes mellitus	5.51e-05	0.000231	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CTLA4—type 1 diabetes mellitus	5.44e-05	0.000228	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	5.42e-05	0.000228	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD80—type 1 diabetes mellitus	5.4e-05	0.000227	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	5.38e-05	0.000226	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS2—type 1 diabetes mellitus	5.32e-05	0.000223	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	5.23e-05	0.000219	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—KCNJ11—type 1 diabetes mellitus	5.23e-05	0.000219	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	5.21e-05	0.000218	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD79A—type 1 diabetes mellitus	5.19e-05	0.000218	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD80—type 1 diabetes mellitus	5.19e-05	0.000218	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD80—type 1 diabetes mellitus	5.16e-05	0.000217	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.15e-05	0.000216	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	5.15e-05	0.000216	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—type 1 diabetes mellitus	5.11e-05	0.000215	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	5.1e-05	0.000214	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRKCQ—type 1 diabetes mellitus	5.09e-05	0.000214	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—EGFR—type 1 diabetes mellitus	5.09e-05	0.000213	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—type 1 diabetes mellitus	5.09e-05	0.000213	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CD4—type 1 diabetes mellitus	5.09e-05	0.000213	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	5.08e-05	0.000213	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL2—type 1 diabetes mellitus	5.07e-05	0.000213	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HBA2—type 1 diabetes mellitus	5.05e-05	0.000212	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS1—type 1 diabetes mellitus	5.02e-05	0.000211	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CD86—type 1 diabetes mellitus	4.96e-05	0.000208	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—VAV1—type 1 diabetes mellitus	4.95e-05	0.000208	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	4.93e-05	0.000207	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—INS—type 1 diabetes mellitus	4.88e-05	0.000205	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQA1—type 1 diabetes mellitus	4.79e-05	0.000201	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	4.78e-05	0.000201	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	4.77e-05	0.0002	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	4.75e-05	0.000199	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	4.7e-05	0.000197	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PRKCQ—type 1 diabetes mellitus	4.7e-05	0.000197	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	4.67e-05	0.000196	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CD80—type 1 diabetes mellitus	4.66e-05	0.000196	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	4.63e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Disease—VAV1—type 1 diabetes mellitus	4.57e-05	0.000192	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—TYK2—type 1 diabetes mellitus	4.56e-05	0.000191	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQB1—type 1 diabetes mellitus	4.48e-05	0.000188	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.47e-05	0.000188	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	4.42e-05	0.000186	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	4.41e-05	0.000185	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—INS—type 1 diabetes mellitus	4.41e-05	0.000185	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	4.4e-05	0.000185	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.4e-05	0.000185	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOC3—type 1 diabetes mellitus	4.37e-05	0.000183	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IAPP—type 1 diabetes mellitus	4.37e-05	0.000183	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TYK2—type 1 diabetes mellitus	4.36e-05	0.000183	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.33e-05	0.000182	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD86—type 1 diabetes mellitus	4.31e-05	0.000181	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS3—type 1 diabetes mellitus	4.28e-05	0.00018	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—STAT3—type 1 diabetes mellitus	4.26e-05	0.000179	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.26e-05	0.000179	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.24e-05	0.000178	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—type 1 diabetes mellitus	4.23e-05	0.000177	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	4.2e-05	0.000176	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD8A—type 1 diabetes mellitus	4.18e-05	0.000175	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—type 1 diabetes mellitus	4.17e-05	0.000175	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	4.16e-05	0.000175	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	4.15e-05	0.000174	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	4.13e-05	0.000173	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—type 1 diabetes mellitus	4.12e-05	0.000173	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	4.12e-05	0.000173	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	4.05e-05	0.00017	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-B—type 1 diabetes mellitus	4.02e-05	0.000169	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	4.02e-05	0.000169	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD86—type 1 diabetes mellitus	3.98e-05	0.000167	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	3.96e-05	0.000166	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD4—type 1 diabetes mellitus	3.96e-05	0.000166	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—type 1 diabetes mellitus	3.94e-05	0.000165	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.94e-05	0.000165	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—STAT3—type 1 diabetes mellitus	3.94e-05	0.000165	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—type 1 diabetes mellitus	3.91e-05	0.000164	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ERBB3—type 1 diabetes mellitus	3.89e-05	0.000163	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—EGFR—type 1 diabetes mellitus	3.88e-05	0.000163	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.86e-05	0.000162	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SST—type 1 diabetes mellitus	3.84e-05	0.000161	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.82e-05	0.00016	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	3.78e-05	0.000159	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2RA—type 1 diabetes mellitus	3.77e-05	0.000158	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-A—type 1 diabetes mellitus	3.73e-05	0.000156	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CD80—type 1 diabetes mellitus	3.62e-05	0.000152	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	3.61e-05	0.000151	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ERBB3—type 1 diabetes mellitus	3.59e-05	0.000151	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—EGFR—type 1 diabetes mellitus	3.58e-05	0.00015	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—type 1 diabetes mellitus	3.56e-05	0.000149	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	3.53e-05	0.000148	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CCR5—type 1 diabetes mellitus	3.53e-05	0.000148	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HLA-A—type 1 diabetes mellitus	3.44e-05	0.000144	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GCG—type 1 diabetes mellitus	3.42e-05	0.000144	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—INS—type 1 diabetes mellitus	3.42e-05	0.000143	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—type 1 diabetes mellitus	3.41e-05	0.000143	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.31e-05	0.000139	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3.29e-05	0.000138	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.28e-05	0.000138	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—type 1 diabetes mellitus	3.28e-05	0.000137	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.26e-05	0.000137	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	3.25e-05	0.000137	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	3.23e-05	0.000135	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VAV1—type 1 diabetes mellitus	3.2e-05	0.000134	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.19e-05	0.000134	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	3.19e-05	0.000134	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD80—type 1 diabetes mellitus	3.15e-05	0.000132	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.05e-05	0.000128	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—STAT3—type 1 diabetes mellitus	3.05e-05	0.000128	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	3.04e-05	0.000127	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	3.03e-05	0.000127	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	3e-05	0.000126	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3e-05	0.000126	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—type 1 diabetes mellitus	2.99e-05	0.000126	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	2.98e-05	0.000125	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—type 1 diabetes mellitus	2.98e-05	0.000125	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	2.93e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD80—type 1 diabetes mellitus	2.9e-05	0.000122	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—EGFR—type 1 diabetes mellitus	2.9e-05	0.000122	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.9e-05	0.000121	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.88e-05	0.000121	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.85e-05	0.00012	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CD86—type 1 diabetes mellitus	2.79e-05	0.000117	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—EGFR—type 1 diabetes mellitus	2.79e-05	0.000117	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—EGFR—type 1 diabetes mellitus	2.77e-05	0.000116	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.76e-05	0.000116	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—type 1 diabetes mellitus	2.75e-05	0.000115	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	2.75e-05	0.000115	CbGpPWpGaD
Tacrolimus—MTOR—Disease—INS—type 1 diabetes mellitus	2.74e-05	0.000115	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	2.73e-05	0.000115	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.73e-05	0.000114	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	2.69e-05	0.000113	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TYK2—type 1 diabetes mellitus	2.66e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.65e-05	0.000111	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HBA1—type 1 diabetes mellitus	2.58e-05	0.000108	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOC3—type 1 diabetes mellitus	2.57e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2.56e-05	0.000108	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.54e-05	0.000107	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—type 1 diabetes mellitus	2.54e-05	0.000107	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	2.52e-05	0.000106	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.51e-05	0.000106	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.51e-05	0.000105	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—type 1 diabetes mellitus	2.49e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.47e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TYK2—type 1 diabetes mellitus	2.45e-05	0.000103	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	2.44e-05	0.000103	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.44e-05	0.000102	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS3—type 1 diabetes mellitus	2.41e-05	0.000101	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	2.41e-05	0.000101	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—type 1 diabetes mellitus	2.4e-05	0.000101	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	2.33e-05	9.79e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	2.26e-05	9.5e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	2.25e-05	9.44e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—type 1 diabetes mellitus	2.23e-05	9.36e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	2.22e-05	9.32e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—type 1 diabetes mellitus	2.22e-05	9.31e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—type 1 diabetes mellitus	2.22e-05	9.31e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	2.21e-05	9.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—type 1 diabetes mellitus	2.21e-05	9.27e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.14e-05	8.97e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—type 1 diabetes mellitus	2.13e-05	8.95e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—type 1 diabetes mellitus	2.07e-05	8.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CD80—type 1 diabetes mellitus	2.03e-05	8.54e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GCG—type 1 diabetes mellitus	2.01e-05	8.43e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	1.98e-05	8.29e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.94e-05	8.15e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.94e-05	8.13e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—type 1 diabetes mellitus	1.93e-05	8.08e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—INS—type 1 diabetes mellitus	1.92e-05	8.06e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—STAT3—type 1 diabetes mellitus	1.86e-05	7.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.86e-05	7.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	1.81e-05	7.61e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.76e-05	7.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.76e-05	7.37e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.72e-05	7.21e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—STAT3—type 1 diabetes mellitus	1.72e-05	7.2e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.7e-05	7.14e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—EGFR—type 1 diabetes mellitus	1.69e-05	7.09e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.69e-05	7.07e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	1.66e-05	6.98e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	1.59e-05	6.68e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—EGFR—type 1 diabetes mellitus	1.56e-05	6.55e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.49e-05	6.27e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.49e-05	6.26e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.48e-05	6.22e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.43e-05	6e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—type 1 diabetes mellitus	1.43e-05	6e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.4e-05	5.85e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.39e-05	5.82e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.36e-05	5.71e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	1.31e-05	5.5e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—type 1 diabetes mellitus	1.3e-05	5.45e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.2e-05	5.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	1.2e-05	5.04e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—type 1 diabetes mellitus	1.2e-05	5.03e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	1.15e-05	4.83e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—INS—type 1 diabetes mellitus	1.13e-05	4.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.09e-05	4.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	1.08e-05	4.55e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—type 1 diabetes mellitus	9.9e-06	4.16e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—INS—type 1 diabetes mellitus	9.9e-06	4.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	9.18e-06	3.85e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	9.07e-06	3.81e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	8.68e-06	3.64e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—type 1 diabetes mellitus	8.4e-06	3.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	6.1e-06	2.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	5.59e-06	2.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	5.35e-06	2.24e-05	CbGpPWpGaD
